ArticlePloS one2025
In vitro characterization of Trichophyton rubrum biofilm by combined anti-biofilm enzymes.
Article in PloS one, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Efficacy of Berberine-Mediated Photodynamic Therapy Against Trichophyton rubrum Infection.Lasers in surgery and medicine · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Trichophyton rubrum, a dermatophyte, demonstrates a notable ability to form mature biofilms on skin and associated surfaces, strengthening its resistance to antifungal agents. This characteristic poses intricate challenges in dermatological research and therapeutic strategies, underscoring the need for innovative approaches to effectively manage fungal infections. This work assessed the impact of the anti-biofilm enzymes, i.e., cellulase, protease, and amylase, individually and in combination, on the eradication and inhibition of T. rubrum biofilm. After 168 hours of incubation, T. rubrum biofilm formation matured, and the anti-biofilm enzymes significantly reduced the rate of biofilm development. The rates of biofilm inhibition and eradication for cellulase, protease, and amylase were 64%, 38%, and 28% at 72 hours of incubation, and 47%, 25.87%, and 17%, respectively, at 168 hours. However, the combined anti-biofilm enzymes (cellulase, protease, and amylase) had a 60.62% biofilm suppression rate. SEM analysis revealed marked reductions in T. rubrum conidial density, disrupted hyphal structures, and diminished biofilm adherence in enzyme-treated samples compared to untreated controls, visually supporting the inhibitory effect observed in quantitative assays. These morphological alterations indicate compromised fungal viability and structural disintegration of the biofilm matrix. Collectively, the SEM findings reinforce the therapeutic potential of enzyme-based strategies against dermatophytic biofilms. Additionally, these anti-biofilm enzymes have shown strong efficacy in reducing the exopolysaccharide (EPS) content and degrading the complex EPS matrix network. The T. rubrum biofilm treated with anti-biofilm enzymes, such as cellulase and protease, resulted in EPS degradation by FTIR analysis. The antibiofilm enzyme cellulase showed notable degradation of the beta 1-4 linkage within the glycosidic bond. A significant degradation is observed when T. rubrum biofilm is treated with combined enzymes (cellulase, protease, and amylase). The combined enzymatic treatment disrupted the EPS matrix, indicating its potential as an effective strategy for inhibiting biofilm formation by T. rubrum.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.